Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea

PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in Korean patients with severe asthma. We sought to evaluate the real-world effectiveness of oma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Allergy Asthma Immunol Res
Autors principals: Lee, Ji-Ho, Lee, Hyun Young, Jung, Chang-Gyu, Ban, Ga-Young, Shin, Yoo Seob, Ye, Young-Min, Nahm, Dong-Ho, Park, Hae-Sim
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809760/
https://ncbi.nlm.nih.gov/pubmed/29411552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2018.10.2.121
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars